comparemela.com

Latest Breaking News On - Eur mor de0006632003 - Page 1 : comparemela.com

MORPHOSYS : Raised by UBS | MarketScreener

Initially labeled as a Sell, UBS adopts a positive opinion and now advises the stock as a Buy. The target price is unchanged at EUR 47. | May 31, 2023

MORPHOSYS : Buy rating by UBS | MarketScreener

The analyst Xian Deng has published a positive research note on the stock, which he labeled a Buy. UBS was initially a Sell. The target price is unchanged at EUR 47. | May 31, 2023

MORPHOSYS : Deutsche Bank reiterates its Sell rating

In a research note published by Emmanuel Papadakis, Deutsche Bank advises its customers to Sell the stock. The target price continues to be set at EUR 13. | May 15, 2023

MORPHOSYS : Goldman Sachs gives a Sell rating

Rajan Sharma from Goldman Sachs retains his negative opinion on the stock with a Sell rating. The target price is unchanged and still at EUR 12.50. | May 8, 2023

MORPHOSYS : JP Morgan reiterates its Sell rating

JP Morgan analyst James Gordon reiterate his Sell rating on the stock. The target price has been raised to EUR 12 from EUR 11. | May 5, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.